My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Positive correlation between vitreous levels of advanced glycation end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently treated with photocoagulation.

    Yokoi M, Yamagishi S, Takeuchi M, Matsui T, Yoshida Y, Ohgami K, Amano-Okamoto T, Ohno S.

    Br J Ophthalmol. 2007 Mar;91(3):397-8. No abstract available. PMID: 17322470 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Relationship between vascular endothelial growth factors and advanced glycation end products in the human vitreous]

    Hashimoto H, Arai K, Chikuda M, Obara Y.

    Nippon Ganka Gakkai Zasshi. 1998 Jul;102(7):442-6. Japanese. PMID: 9720366 [PubMed - indexed for MEDLINE]Related articles

    3.

    Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation.

    Spranger J, Hammes HP, Preissner KT, Schatz H, Pfeiffer AF.

    Diabetologia. 2000 Nov;43(11):1404-7.PMID: 11126410 [PubMed - indexed for MEDLINE]Related articles

    4.

    The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.

    Murata T, Nagai R, Ishibashi T, Inomuta H, Ikeda K, Horiuchi S.

    Diabetologia. 1997 Jul;40(7):764-9.PMID: 9243096 [PubMed - indexed for MEDLINE]Related articles

    5.

    Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.

    Yokoi M, Yamagishi SI, Takeuchi M, Ohgami K, Okamoto T, Saito W, Muramatsu M, Imaizumi T, Ohno S.

    Br J Ophthalmol. 2005 Jun;89(6):673-5.PMID: 15923499 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.

    Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H, Kondo M.

    Biochem Biophys Res Commun. 1997 Jul 30;236(3):712-5.PMID: 9245719 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity.

    Simó R, Lecube A, García-Arumí J, Carrasco E, Hernández C.

    Diabetes Care. 2004 Jan;27(1):287-8. No abstract available. PMID: 14694016 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.

    Endo M, Yanagisawa K, Tsuchida K, Okamoto T, Matsushita T, Higuchi M, Matsuda A, Takeuchi M, Makita Z, Koike T.

    Horm Metab Res. 2001 May;33(5):317-22.PMID: 11440280 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy]

    Matsumoto Y, Takahashi M, Ogata M.

    Nippon Ganka Gakkai Zasshi. 2001 Jul;105(7):435-41. Japanese. PMID: 11510106 [PubMed - indexed for MEDLINE]Related articles

    10.

    Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy.

    Matsumoto Y, Takahashi M, Ogata M.

    Jpn J Ophthalmol. 2002 Jul-Aug;46(4):406-12.PMID: 12225819 [PubMed - indexed for MEDLINE]Related articles

    11.

    Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.

    Hernández C, Burgos R, Cantón A, García-Arumí J, Segura RM, Simó R.

    Diabetes Care. 2001 Mar;24(3):516-21.PMID: 11289478 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.

    Hernández C, Lecube A, Segura RM, Sararols L, Simó R.

    Diabet Med. 2002 Aug;19(8):655-60.PMID: 12147146 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.

    Kakehashi A, Inoda S, Mameuda C, Kuroki M, Jono T, Nagai R, Horiuchi S, Kawakami M, Kanazawa Y.

    Diabetes Res Clin Pract. 2008 Mar;79(3):438-45. Epub 2007 Nov 28.PMID: 18053608 [PubMed - indexed for MEDLINE]Related articles

    14.

    Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.

    Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A.

    Diabetologia. 1997 Sep;40(9):1107-9.PMID: 9300249 [PubMed - indexed for MEDLINE]Related articles

    15.

    Management of proliferative diabetic retinopathy.

    Gündüz K, Bakri SJ.

    Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Review.PMID: 18201511 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.

    Nakamura N, Hasegawa G, Obayashi H, Yamazaki M, Ogata M, Nakano K, Yoshikawa T, Watanabe A, Kinoshita S, Fujinami A, Ohta M, Imamura Y, Ikeda T.

    Diabetes Res Clin Pract. 2003 Aug;61(2):93-101.PMID: 12951277 [PubMed - indexed for MEDLINE]Related articles

    17.

    Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.

    Malik RA, Li C, Aziz W, Olson JA, Vohra A, McHardy KC, Forrester JV, Boulton AJ, Wilson PB, Liu D, McLeod D, Kumar S.

    J Cell Mol Med. 2005 Jul-Sep;9(3):692-7.PMID: 16202216 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Cytokines in the vitreous fluid of patients with proliferative diabetic retinopathy--vascular endothelial growth factor and platelet-derived growth factor are elevated in proliferative diabetic retinopathy]

    Endo H, Naito T, Asahara T, Kajima M, Shiota H.

    Nippon Ganka Gakkai Zasshi. 2000 Oct;104(10):711-6. Japanese. PMID: 11081306 [PubMed - indexed for MEDLINE]Related articles

    19.

    Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

    Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al.

    N Engl J Med. 1994 Dec 1;331(22):1480-7.PMID: 7526212 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Immunodetection of vascular endothelial growth factor in the vitreous of eyes with proliferative diabetic retinopathy]

    Ozaki H, Hayashi H, Oshima K, Imanaga Y, Kuroki M, Arakawa F, Kuwahara M, Matsuoka Y.

    Nippon Ganka Gakkai Zasshi. 1996 Mar;100(3):208-12. Japanese. PMID: 8900585 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity